India's pharmaceutical industry: hype or high tech take-off?

Area of Science:

• Pharmaceutical industry
• Global trade and economics
• Intellectual property law

Background:

• India's pharmaceutical sector has grown significantly due to supportive government policies.
• Historically, the lack of product patents allowed Indian firms to excel in generic drug production.
• Competitive advantages include low manufacturing costs and a robust engineering base.

Purpose of the Study:

• To describe the evolution and structure of the Indian pharmaceutical industry.
• To analyze the impact of the World Trade Organization patent regime implemented in 2005.
• To explore challenges and opportunities arising from global market integration.

Main Methods:

• Descriptive analysis of industry development.
• Examination of policy impacts (e.g., patent regime changes).
• Review of market dynamics and company strategies.

Main Results:

• The 2005 World Trade Organization patent implementation is transforming the industry.
• Increased presence of multinational pharmaceutical corporations ('big pharma').
• Emergence of Indian companies aspiring to become global research-based multinationals.

Conclusions:

• The Indian pharmaceutical industry is undergoing a significant shift post-2005 patent regime.
• Integration into global markets presents both challenges and opportunities for growth and innovation.
• The industry is evolving from a generics-focused model to one with research and development ambitions.